{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:59:32Z","timestamp":1791939572637,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vetimm.2011.06.008","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T21:11:39Z","timestamp":1309036299000},"page":"301-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Use of recombinant interferon omega in feline retrovirosis: From theory to practice"],"prefix":"10.1016","volume":"143","author":[{"given":"Ana","family":"Dom\u00e9nech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victorio M.","family":"Collado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Sanjos\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Escolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonsoles","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Gomez-Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2011.06.008_bib0005","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1177\/1352458519950101044","article-title":"Human interferon omega \u2013 a review","volume":"1","author":"Adolf","year":"1995","journal-title":"Mult. Scler."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/inpract.27.9.454","article-title":"Antiviral therapy in cats: current rationale and recommendations","volume":"27","author":"Caney","year":"2005","journal-title":"In Pract."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0015","series-title":"Proceedings of the annual conference of the American College of Veterinary Internal Medicine","article-title":"Treatment of asymptomatic chronically FIV-infected cats with recombinant feline interferon omega","author":"Caney","year":"2003"},{"key":"10.1016\/j.vetimm.2011.06.008_bib0020","first-page":"68","article-title":"Usos del interfer\u00f3n en la cl\u00ednica de peque\u00f1os animales","volume":"63","author":"Collado","year":"2006","journal-title":"Peque\u00f1os Animales"},{"key":"10.1016\/j.vetimm.2011.06.008_bib0025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.vetmic.2007.03.008","article-title":"Effect of type I interferons on the expression of feline leukaemia virus","volume":"123","author":"Collado","year":"2007","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0030","unstructured":"Collado, V.M., Domenech, A., Mir\u00f3, G., Mart\u00edn, S., Escolar, E., Ballesteros, N., Sanjos\u00e9, L., Gomez-Lucia, E. Epidemiological aspects and clinicopathological findings in cats naturally infected with feline leukemia virus (FeLV) and\/or feline immunodeficiency virus (FIV). J. Am. Vet. Med. Assoc., submitted for publication."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0035","first-page":"513","article-title":"Oral use of human alpha interferon in cats","volume":"7","author":"Cummins","year":"1988","journal-title":"J. Biol. Response Mod."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0040","first-page":"477","article-title":"Therapeutic effects of recombinant feline interferon-omega on feline leukaemia virus (FeLV)-infected and FeLV\/Feline immunodeficiency virus (FIV)-coinfected symptomatic cats","volume":"18","author":"De Mari","year":"2004","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0045","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cvsm.2008.03.005","article-title":"Retroviral infections of small animals","volume":"38","author":"Dunham","year":"2008","journal-title":"Vet. Clin. Small Anim."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0050","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1128\/JVI.80.7.3438-3444.2006","article-title":"Effects of type I interferons on Friend retrovirus infections","volume":"80","author":"Gerlach","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/eji.200838311","article-title":"Anti-retroviral effects of type I IFN subtypes in vivo","volume":"39","author":"Gerlach","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0060","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/v1030545","article-title":"Effect of type-I interferon on retroviruses","volume":"1","author":"G\u00f3mez-Luc\u00eda","year":"2009","journal-title":"Viruses"},{"key":"10.1016\/j.vetimm.2011.06.008_bib0065","series-title":"Infectious Diseases of the Dog and the Cat","first-page":"105","article-title":"Feline leukaemia virus infection","author":"Hartmann","year":"2006"},{"key":"10.1016\/j.vetimm.2011.06.008_bib0070","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1093\/nar\/13.13.4739","article-title":"A novel class of human type I interferons","volume":"13","author":"Hauptmann","year":"1985","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0075","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1749-6632.1990.tb17846.x","article-title":"Therapy of presymptomatic FeLV-induced immunodeficiency syndrome with AZT in combination with alpha interferon","volume":"616","author":"Hoover","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jfms.2003.08.011","article-title":"Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis","volume":"6","author":"Ishida","year":"2004","journal-title":"J. Feline Med. Surg."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0166-3542(83)90033-5","article-title":"Inhibition of feline leukemia virus replication by human leukocyte interferon","volume":"3","author":"Jameson","year":"1983","journal-title":"Antiviral Res."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0090","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1016\/j.vaccine.2007.11.060","article-title":"The emerging role of innate immunity in protection against HIV-1 infection","volume":"26","author":"Lehner","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vetimm.2011.06.008_bib0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0166-0934(98)00166-9","article-title":"Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system","volume":"78","author":"Leutenegger","year":"1999","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.vetimm.2011.06.008_bib0100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5326\/15473317-37-4-356","article-title":"Immunomodulation therapy for feline leukemia virus infection","volume":"37","author":"McCaw","year":"2001","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1439-0442.2007.00902.x","article-title":"Plasma electrophoretogram in feline immunodeficiency virus (FIV) and\/or feline leukaemia virus (FeLV) infections","volume":"54","author":"Miro","year":"2007","journal-title":"J. Vet. Med. A"},{"key":"10.1016\/j.vetimm.2011.06.008_bib0110","first-page":"51","article-title":"Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro","volume":"69","author":"Mochizuki","year":"1994","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0115","first-page":"334","article-title":"Interferon therapy in dogs and cats","volume":"8","author":"M\u00fcller","year":"2002","journal-title":"Kleintiermedizin"},{"key":"10.1016\/j.vetimm.2011.06.008_bib0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1271\/bbb.56.211","article-title":"Molecular cloning of feline interferon cDNA by direct expression","volume":"56","author":"Nakamura","year":"1992","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11259-007-9019-5","article-title":"Sensitivity of FCV to recombinant feline interferon (rFeIFN)","volume":"32","author":"Ohe","year":"2008","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.vetimm.2007.04.007","article-title":"Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-\u03c9 administration","volume":"118","author":"Paltrinieri","year":"2007","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.vetimm.2005.08.020","article-title":"Low-dose interferon-\u03b1 treatment for feline immunodeficiency virus infection","volume":"109","author":"Pedretti","year":"2006","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jfms.2006.05.008","article-title":"Diagnosis of feline leukaemia virus infection by semi-quantitative real-time polymerase reaction","volume":"9","author":"Pinches","year":"2007","journal-title":"J. Feline Med. Surg."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1023\/B:VERC.0000014196.13712.69","article-title":"Effects of interferon-alpha (IFN-\u03b1) therapy on peripheral blood lymphocyte subsets from FIV and FEV naturally infected cats","volume":"27","author":"Riondato","year":"2003","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0155","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/jir.1998.18.805","article-title":"The evolution of the type I interferons","volume":"18","author":"Roberts","year":"1998","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0160","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/newbio237270a0","article-title":"Cat interferon inhibits feline leukaemia virus infection in cell culture","volume":"237","author":"Rogers","year":"1972","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0165","series-title":"Infectious Diseases of the Dog and the Cat","first-page":"131","article-title":"Feline immunodeficiency virus infection","author":"Sellon","year":"2006"},{"key":"10.1016\/j.vetimm.2011.06.008_bib0170","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.micro.55.1.255","article-title":"Viruses and interferons","volume":"55","author":"Sen","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0175","first-page":"24","article-title":"Improved survival of four cats infected with feline leukemia virus after oral administration of interferon","volume":"17","author":"Steed","year":"1987","journal-title":"Feline Pract."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0180","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/107999001317205169","article-title":"Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-\u03b3","volume":"21","author":"Tanabe","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0185","first-page":"862","article-title":"A study of the antiviral activity of interferon-omega (IFN-\u03c9) against selected canine and feline viruses","volume":"10","author":"Truyen","year":"2002","journal-title":"J. Mod. Vet. Med."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0190","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1292\/jvms.55.251","article-title":"Homogeneous production of feline interferon in silkworm by replacing single amino acid code in signal peptide region in recombinant baculovirus and characterization of the product","volume":"55","author":"Ueda","year":"1993","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1292\/jvms.55.1","article-title":"Pharmacokinetic properties of recombinant feline interferon and its stimulatory effect on 2\u2032,5\u2032-oligoadenylate synthetase activity in the cat","volume":"55","author":"Ueda","year":"1993","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0200","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.2460\/javma.1991.199.10.1477","article-title":"Low-dose orally administered alpha interferon treatment for feline leukemia virus infection","volume":"199","author":"Weiss","year":"1991","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-2427(02)00188-5","article-title":"Cloning, expression, purification, and biological activity of five feline type I interferons","volume":"89","author":"Wonderling","year":"2002","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-2427(86)90084-X","article-title":"A feline retrovirus induced T-lymphoblastoid cell-line that produces an atypical \u03b1 type of interferon","volume":"11","author":"Yamamoto","year":"1986","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2011.06.008_bib0215","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1128\/AAC.34.9.1749","article-title":"Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukaemia virus-induced immunodeficiency syndrome","volume":"34","author":"Zeidner","year":"1990","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242711002054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242711002054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:21:09Z","timestamp":1759044069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242711002054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":43,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0165242711002054"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2011.06.008","relation":{},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of recombinant interferon omega in feline retrovirosis: From theory to practice","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2011.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}